ProKidney Corp (PROK)
NASDAQ · Healthcare
ProKidney Corp EBITDA 2022–2025
ProKidney Corp annual/quarterly ebitda history and growth rate from 2022 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- ProKidney Corp ebitda for the quarter ending March 31, 2026 was -43.3 M, a 8.76% increase year-over-year.
- ProKidney Corp annual ebitda for 2025 was -158.4 M, a 11.12% decrease from 2024.
- ProKidney Corp annual ebitda for 2024 was -178.2 M, a 20.71% increase from 2023.
- ProKidney Corp annual ebitda for 2023 was -147.7 M, a 1.53% decrease from 2022.
- ProKidney Corp annual ebitda for 2022 was -150.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ProKidney Corp EBITDA — FAQ
ProKidney Corp (PROK) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PROK's ebitda history?
The chart and table above show ProKidney Corp's ebitda by year and by quarter, including the growth rate.